JP2022501063A5 - - Google Patents

Info

Publication number
JP2022501063A5
JP2022501063A5 JP2021518942A JP2021518942A JP2022501063A5 JP 2022501063 A5 JP2022501063 A5 JP 2022501063A5 JP 2021518942 A JP2021518942 A JP 2021518942A JP 2021518942 A JP2021518942 A JP 2021518942A JP 2022501063 A5 JP2022501063 A5 JP 2022501063A5
Authority
JP
Japan
Prior art keywords
protein
variant
polypeptide
polypeptide according
sac7d
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021518942A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022501063A (ja
JP7699539B2 (ja
Filing date
Publication date
Priority claimed from EP18306324.7A external-priority patent/EP3632924A1/en
Application filed filed Critical
Publication of JP2022501063A publication Critical patent/JP2022501063A/ja
Publication of JP2022501063A5 publication Critical patent/JP2022501063A5/ja
Priority to JP2025064215A priority Critical patent/JP2025108528A/ja
Application granted granted Critical
Publication of JP7699539B2 publication Critical patent/JP7699539B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021518942A 2018-10-07 2019-10-06 多量体タンパク質の形成を阻害するバインダー Active JP7699539B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025064215A JP2025108528A (ja) 2018-10-07 2025-04-09 多量体タンパク質の形成を阻害するバインダー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18306324.7A EP3632924A1 (en) 2018-10-07 2018-10-07 Binders for inhibiting formation of multimeric proteins
EP18306324.7 2018-10-07
PCT/EP2019/076986 WO2020074402A1 (en) 2018-10-07 2019-10-06 Binders for inhibiting formation of multimeric proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025064215A Division JP2025108528A (ja) 2018-10-07 2025-04-09 多量体タンパク質の形成を阻害するバインダー

Publications (3)

Publication Number Publication Date
JP2022501063A JP2022501063A (ja) 2022-01-06
JP2022501063A5 true JP2022501063A5 (cg-RX-API-DMAC7.html) 2022-10-07
JP7699539B2 JP7699539B2 (ja) 2025-06-27

Family

ID=64017330

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021518942A Active JP7699539B2 (ja) 2018-10-07 2019-10-06 多量体タンパク質の形成を阻害するバインダー
JP2025064215A Pending JP2025108528A (ja) 2018-10-07 2025-04-09 多量体タンパク質の形成を阻害するバインダー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025064215A Pending JP2025108528A (ja) 2018-10-07 2025-04-09 多量体タンパク質の形成を阻害するバインダー

Country Status (5)

Country Link
US (1) US20210380647A1 (cg-RX-API-DMAC7.html)
EP (2) EP3632924A1 (cg-RX-API-DMAC7.html)
JP (2) JP7699539B2 (cg-RX-API-DMAC7.html)
ES (1) ES3068042T3 (cg-RX-API-DMAC7.html)
WO (1) WO2020074402A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3004650B1 (fr) * 2013-04-22 2015-05-29 Affilogic Composition topique comprenant un variant d'une protéine sauvage à pli-OB, ainsi que son procédé de préparation
EP4043481A1 (en) 2021-02-15 2022-08-17 Affilogic Compounds and methods for extending half life of biomolecules
EP4190358A1 (en) 2021-12-05 2023-06-07 Affilogic Polypeptide as carrier for intestinal barrier crossing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007011891A2 (en) * 2005-07-15 2007-01-25 Strategene California Dna binding protein-polymerase chimeras
ZA200810836B (en) 2006-05-26 2010-07-28 Obodies Ltd OB fold domains
EP1930342B1 (en) * 2006-12-04 2012-01-25 Institut Pasteur OB-fold used as scaffold for engineering new specific binders
FR2974816A1 (fr) 2011-05-04 2012-11-09 Centre Nat Rech Scient Methode de generation de proteines
FR3004650B1 (fr) 2013-04-22 2015-05-29 Affilogic Composition topique comprenant un variant d'une protéine sauvage à pli-OB, ainsi que son procédé de préparation
FR3027521B1 (fr) 2014-10-24 2016-12-16 Affilogic Compositions pour administration par voie orale
WO2017161096A1 (en) * 2016-03-16 2017-09-21 Tarveda Therapeutics, Inc. Antibody mimic conjugates and particles
EP3483180A1 (en) * 2017-11-14 2019-05-15 Affilogic Multi specific molecules

Similar Documents

Publication Publication Date Title
CN110582566B (zh) 肽连接酶及其用途
US8192953B2 (en) Trimerising module
AU2016293063B2 (en) Novel immunoglobulin-binding proteins and their use in affinity purification
JP5868346B2 (ja) 抗体模倣物および他の結合タンパク質のためのタンパク質骨格
US20170334958A1 (en) Protein scaffolds for antibody mimics and other binding proteins
AU2002213251A1 (en) Protein scaffolds for antibody mimics and other binding proteins
AU2018266091B2 (en) Multispecific protein drug and library thereof, preparing method therefor and application thereof
CN111032864A (zh) 具有半衰期延长多肽的融合蛋白
CN101415721A (zh) 用于纯化和结晶目的分子的组合物
CN107073093A (zh) 亲和蛋白及其用途
Yesilcimen et al. Rapid Production of Native and Mirror-Image Tumor Necrosis Factor-α Enabled by Automated Flow Peptide Synthesis Technology
EP4053311A1 (en) Half-life extension drug and library thereof, and preparation method and application thereof
CN108300725A (zh) 可溶性单链抗体超抗原融合基因及蛋白和其制备与应用
CN107964041B (zh) 高稳定性和高亲和力的dmic及其制法
JP2026509661A (ja) ヘリコバクター・ピロリ由来のフコシルトランスフェラーゼ変異体
CN111909268B (zh) 低免疫原性低ADCC/CDC功能抗TNF-α人源化单克隆抗体TCX060及其应用
KR102140557B1 (ko) 단백질-단백질 결합체를 형성 매개 펩타이드 및 이를 이용한 단백질-단백질 결합체 형성 방법
CN113583125B (zh) 抗体以及包含其的结合剂、免疫吸附材料及其应用
CN112442496A (zh) 精氨酸脱亚胺酶突变体及其应用
CN121627837A (zh) 针对转铁蛋白受体的多肽及其在药物递送中的应用
Gao et al. Preparation of the immobilized α1A-adrenoceptor column by the ultra-high affinity protein pair CL7/Im7 and its application in drug-protein interaction analysis
WO2023099783A1 (en) Polypeptide as carrier for intestinal barrier crossing
JPH05262788A (ja) ペプチド類、その設計方法及び製造方法並びに受容体上の生理活性ペプチドの結合部位の決定方法
CN121319150A (zh) 一种同时识别hbv核心抗原表位及包膜蛋白表位的tcr及其编码序列
CN116261568A (zh) 用于补体因子h(cfh)的结合蛋白